Burning Rock Biotech (BNR) Inventory Average (2020 - 2026)

Burning Rock Biotech's Inventory Average history runs 7 years deep, the most recent figure standing at $8.0 million for Q1 2026.

• In Q1 2026, Inventory Average fell 3.62% year-over-year to $8.0 million; the TTM figure through Mar 2026 stood at $8.0 million (down 3.62% YoY), while the FY2025 annual figure was $7.8 million, down 15.16% from the prior year.
• Inventory Average for Q1 2026 stood at $8.0 million, up from $7.8 million in the prior quarter.
• The five-year high for Inventory Average was $20.3 million in Q3 2022, with the low at $7.8 million in Q4 2025.
• The 5-year median for Inventory Average is $9.3 million (2024), against an average of $12.5 million.
• The sharpest annual moves came in 2022 and 2024: Inventory Average jumped 58.06% in 2022, then tumbled 47.5% in 2024.
• Burning Rock Biotech's Inventory Average stood at $19.7 million in 2022, then sank by 45.67% to $10.7 million in 2023, then dropped by 20.95% to $8.5 million in 2024, then retreated by 7.48% to $7.8 million in 2025, then advanced by 1.4% to $8.0 million in 2026.
• Business Quant data shows BNR's Inventory Average at $8.0 million in Q1 2026, $7.8 million in Q4 2025, and $7.9 million in Q3 2025.